(Q24309534)

Nuclear factor I X

1 reference

positive regulation of transcription by RNA polymerase II

1 reference

Nuclear factor I/X

1 reference

Functionally conserved xenobiotic responsive enhancer in cytochrome P450 3A7.

author name string

Amanda K Riffel

series ordinal

1

0 references

Eric Schuenemann

series ordinal

2

0 references

Carrie A Vyhlidal

series ordinal

3

0 references

language of work or name

English

0 references

publication date

November 2009

0 references

published in

Molecular Pharmacology

0 references

volume

76

0 references

issue

5

0 references

page(s)

1104-14

0 references

cites work

1 reference

https://api.crossref.org/works/10.1124%2FMOL.109.055699

7 January 2021

Cooperative regulation of CYP3A5 gene transcription by NF-Y and Sp family members

1 reference

https://api.crossref.org/works/10.1124%2FMOL.109.055699

7 January 2021

Modulation of the liver specific phenotype in the human hepatoblastoma line Hep G2

1 reference

https://api.crossref.org/works/10.1124%2FMOL.109.055699

7 January 2021

Genomic organization of human fetal specific P-450IIIA7 (cytochrome P-450HFLa)-related gene(s) and interaction of transcriptional regulatory factor with its DNA element in the 5' flanking region

1 reference

https://api.crossref.org/works/10.1124%2FMOL.109.055699

7 January 2021

The ontogeny of drug metabolism enzymes and implications for adverse drug events

1 reference

https://api.crossref.org/works/10.1124%2FMOL.109.055699

7 January 2021

Genomic organization, splice products and mouse chromosomal localization of genes for transcription factor Nuclear Factor One

1 reference

https://api.crossref.org/works/10.1124%2FMOL.109.055699

7 January 2021

Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4

1 reference

https://api.crossref.org/works/10.1124%2FMOL.109.055699

7 January 2021

Members of the CAAT/enhancer-binding protein, hepatocyte nuclear factor-1 and nuclear factor-1 families can differentially modulate the activities of the rat alpha-fetoprotein promoter and enhancer

1 reference

https://api.crossref.org/works/10.1124%2FMOL.109.055699

7 January 2021

Specific binding of a cellular DNA replication protein to the origin of replication of adenovirus DNA.

1 reference

https://api.crossref.org/works/10.1124%2FMOL.109.055699

7 January 2021

Delta, a transcription factor that binds to downstream elements in several polymerase II promoters, is a functionally versatile zinc finger protein

1 reference

https://api.crossref.org/works/10.1124%2FMOL.109.055699

7 January 2021

Hepatocyte nuclear factor 3 relieves chromatin-mediated repression of the alpha-fetoprotein gene

1 reference

https://api.crossref.org/works/10.1124%2FMOL.109.055699

7 January 2021

Novel transcriptional regulation of the human CYP3A7 gene by Sp1 and Sp3 through nuclear factor kappa B-like element

1 reference

https://api.crossref.org/works/10.1124%2FMOL.109.055699

7 January 2021

Molecular mechanisms of polymorphic CYP3A7 expression in adult human liver and intestine

1 reference

https://api.crossref.org/works/10.1124%2FMOL.109.055699

7 January 2021

Chromatin-dependent cooperativity between site-specific transcription factors in vivo

1 reference

https://api.crossref.org/works/10.1124%2FMOL.109.055699

7 January 2021

The mouse alpha-fetoprotein promoter is repressed in HepG2 hepatoma cells by hepatocyte nuclear factor-3 (FOXA).

1 reference

https://api.crossref.org/works/10.1124%2FMOL.109.055699

7 January 2021

DNA binding and regulatory effects of transcription factors SP1 and USF at the rat amyloid precursor protein gene promoter

1 reference

https://api.crossref.org/works/10.1124%2FMOL.109.055699

7 January 2021

TRANSFAC: transcriptional regulation, from patterns to profiles

1 reference

https://api.crossref.org/works/10.1124%2FMOL.109.055699

7 January 2021

Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene

1 reference

https://api.crossref.org/works/10.1124%2FMOL.109.055699

7 January 2021

Gene structure of CYP3A4, an adult-specific form of cytochrome P450 in human livers, and its transcriptional control.

1 reference

https://api.crossref.org/works/10.1124%2FMOL.109.055699

7 January 2021

Expression of CYP3A in the human liver--evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth

1 reference

https://api.crossref.org/works/10.1124%2FMOL.109.055699

7 January 2021

Nuclear receptor expression in fetal and pediatric liver: correlation with CYP3A expression.

1 reference

https://api.crossref.org/works/10.1124%2FMOL.109.055699

7 January 2021

Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7.

1 reference

https://api.crossref.org/works/10.1124%2FMOL.109.055699

7 January 2021

Role of Sp1, C/EBP alpha, HNF3, and PXR in the basal- and xenobiotic-mediated regulation of the CYP3A4 gene

1 reference

https://api.crossref.org/works/10.1124%2FMOL.109.055699

7 January 2021

Developmental expression of the major human hepatic CYP3A enzymes

1 reference

https://api.crossref.org/works/10.1124%2FMOL.109.055699

7 January 2021

Variability of CYP3A7 expression in human fetal liver

1 reference

https://api.crossref.org/works/10.1124%2FMOL.109.055699

7 January 2021

The ontogeny of human drug-metabolizing enzymes: phase I oxidative enzymes

1 reference

https://api.crossref.org/works/10.1124%2FMOL.109.055699

7 January 2021

Transcriptional regulation of human CYP3A4 basal expression by CCAAT enhancer-binding protein alpha and hepatocyte nuclear factor-3 gamma

1 reference

https://api.crossref.org/works/10.1124%2FMOL.109.055699

7 January 2021

Nuclear factor 1 is required for both hormone-dependent chromatin remodeling and transcriptional activation of the mouse mammary tumor virus promoter

1 reference

https://api.crossref.org/works/10.1124%2FMOL.109.055699

7 January 2021

Cytochrome P-450 3A4: regulation and role in drug metabolism

1 reference

https://api.crossref.org/works/10.1124%2FMOL.109.055699

7 January 2021

Cytochrome P450 3A: ontogeny and drug disposition

1 reference

https://api.crossref.org/works/10.1124%2FMOL.109.055699

7 January 2021